Role of PPAR-d in diabetic cardiomyopathy

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Although diabetics are at increased risk of structural heart disease from vascular complications, the concept of diabetic cardiomyopathy suggests a direct cellular insult to the myocardium. Several investigations, mainly echocardiographic population-based studies, documented a uniform association between diabetic cardiomyopathy and the presence of cardiac hypertrophy and myocardial stiffness. In the following review, we attempt to provide a comprehensive insight to discuss the possible underlying mechanisms, especially the role of PPARs in diabetic cardiomyopathy.

Cite

CITATION STYLE

APA

Li, Y. X., Cheng, K. C., & Cheng, J. T. (2014). Role of PPAR-d in diabetic cardiomyopathy. In Diabetic Cardiomyopathy: Biochemical and Molecular Mechanisms (pp. 201–212). Springer New York. https://doi.org/10.1007/978-1-4614-9317-4_12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free